Harmony Biosciences director files initial Form 3

Harmony Biosciences Holdings, Inc. director Germano Geno J filed an initial Form 3, which is the SEC’s required first insider ownership report for company officers, directors, and large shareholders.

Rhea-AI Filing Summary

Harmony Biosciences Holdings, Inc. director Germano Geno J filed an initial Form 3, which is the SEC’s required first insider ownership report for company officers, directors, and large shareholders. This filing lists him as a reporting person but does not show any specific share transactions.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Harmony Biosciences (HRMY) Form 3 for Germano Geno J indicate?

The Form 3 shows that Germano Geno J is now a director and reporting person for Harmony Biosciences Holdings, Inc. It is an initial SEC insider ownership report and does not list any specific stock transactions or holdings in the provided data.

Does the Harmony Biosciences (HRMY) Form 3 show any insider stock purchases or sales?

No, the Form 3 data provided shows no insider stock purchases, sales, or option exercises. All transaction counts and share amounts are reported as zero, meaning this filing simply establishes reporting status without recording trading activity.

Who is the reporting person on the Harmony Biosciences (HRMY) Form 3?

The reporting person is Germano Geno J, identified as a director of Harmony Biosciences Holdings, Inc. The filing confirms his role as an insider subject to SEC reporting rules but does not include details of any current share ownership in the excerpt.

Why is a Form 3 important for Harmony Biosciences (HRMY) investors?

Form 3 is important because it establishes which individuals are insiders whose future trades must be reported. For Harmony Biosciences, listing director Germano Geno J as a reporting person sets the baseline for monitoring any later Form 4 or Form 5 filings.

Does the Harmony Biosciences (HRMY) Form 3 include any derivative securities information?

No, the provided Form 3 data shows an empty derivativeSummary and a derivativeTransactionCount of zero. This means no options, warrants, or other derivative positions are disclosed for this reporting person in the excerpted information.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/18/2026 - 09:50 PM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Germano Geno J

(Last) (First) (Middle)

C/O HARMONY BIOSCIENCES HOLDINGS, INC.

630 W GERMANTOWN PIKE, SUITE 215

(Street)

PLYMOUTH MEETING PENNSYLVANIA 19462

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
05/14/2026

3. Issuer Name and Ticker or Trading Symbol
Harmony Biosciences Holdings, Inc. [ HRMY ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Christian Ulrich, Attorney-in-Fact	05/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)